Scilex Holding Company Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Scilex Holding Company (SCLX) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2026-04-10
- Scilex Holding Company effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Scilex Holding Company effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2024 was $2.15M.
- Scilex Holding Company effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2023 was -$1.47M, a 209.21% decline from fiscal 2022.
- Scilex Holding Company effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2022 was $1.35M, a 4245.16% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-10 |
| 2024-12-31 | $2.15M 10-K · filed 2026-04-10 |
| 2023-12-31 | -$1.47M 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.35M 10-K · filed 2024-03-12 |
| 2021-12-31 | $31.00K 10-K · filed 2024-03-12 |
| 2020-12-31 | $93.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |